I. Teulon

发表

Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.

B. Robert, P. Martineau, F. Bibeau, 2007, International journal of radiation oncology, biology, physics.

[Immunotargeting of tumors: state of the art and prospects in 2000].

B. Robert, L. Leserman, F. Buchegger, 2000, Bulletin du cancer.

Llama single‐domain antibodies directed against nonconventional epitopes of tumor‐associated carcinoembryonic antigen absent from nonspecific cross‐reacting antigen

F. Roquet, G. Béhar, A. Gruaz-Guyon, 2009, The FEBS journal.

Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.

F. Pinguet, F. Bressolle, P. Colombo, 2011, Gynecologic oncology.

[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment].

B. Robert, E. Assenat, A. Pèlegrin, 2007, Bulletin du cancer.

Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients.

F. Kraeber-Bodéré, M. Bardiès, J. Pouget, 2013, Immunotherapy.

Interaction of the octapeptide angiotensin II with a high-affinity single-chain Fv and with peptides derived from the antibody paratope.

D. Laune, C. Granier, P. Cohen, 2001, Journal of immunological methods.

Llama single‐domain antibodies directed against nonconventional epitopes of tumor‐associated carcinoembryonic antigen absent from nonspecific cross‐reacting antigen

F. Roquet, G. Béhar, A. Pèlegrin, 2009, The FEBS journal.

Human single-chain Fv fragments from a combinatorial library using the loxP-Cre recombination system.

M. del Río, B. Pau, M. Biard-Piechaczyk, 1999, Human antibodies.

Association d’anticorps anti-EGFR et anti-HER2 : Efficacité pré-clinique dans le traitement du cancer du pancreas

B. Robert, A. Pèlegrin, D. Azria, 2007 .